Protective Effect of Thrombopoietin on Myocardial Cell in Vitro

• 来源期刊: 岭南心血管病杂志（英文版）
• 关键词: thrombopoietin doxorubicin myocardial cells apoptosisAcknowledgment: part of this research was assisted by the laboratory of Paidology Department,Chinese University of Hong Kong
• 年，卷（期）: 2008,（4）
• 页码范围: 193-198
• 页数: 6页
• 语种: 英文

摘要

To investigate the protective effect of thrombopoietin (TPO) on myocardial cells in vitro. Methods H9C2 cell line was maintained in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% calf serum.Beating cells from heart ventricles of neonatal heart were cultured at an in vitro system. Apoptosis of the cell line above was induced by treatment of doxorubicin (DOX) and was blocked by TPO. Cell survival rate of H9C2 cell was measured by the MTr assay. Changes of beating rate of neonatal myocardial cells were captured by digital camera and beating rate was calculated. Flow cytometry was employed to study anti-apoptotic effect of TPO by staining JC-1 protein to H9C2 cell. Results MTT assay demonstrated that doxorubicin reduced cell survival rate by 73.8% + 1.1%, 50 ng * a dose-dependent manner. Beating rate of primary neonatal myocardial cells also decreased to 15% ± 8% at 48 h, 100 11% ± 6% ( P＜ 0. 05 ). Conclusions TPO has protective effect on myocardial cells in vitro. Anti-apoptosis is one of the mechanisms by which TPO protects injured heart.